CD3E and lymphoma: Immunohistochemical analyses demonstrated that these lymphomas exhibited abundant expression of B-cell markers (B220 and CD20) and much weaker expression of the T-cell marker CD3e, confirming their B-cell origin (Fig. 1D and Figs. S2, S3, Supporting Information).